Burning Rock Biotech Ltd. (BNR) has released an update.
Burning Rock Biotech Ltd. has announced a ratio change for its American Depositary Shares (ADSs), effective from May 15, 2024, resulting in a one-for-ten reverse ADS split, with no impact on Class A ordinary shares. The ADSs will continue to trade on the NASDAQ and London Stock Exchange under the ticker ‘BNR’, with the anticipated effect of proportionally increasing the ADS price. This corporate action aims to streamline the company’s equity structure and could potentially affect the market perception and pricing of its shares.
For further insights into BNR stock, check out TipRanks’ Stock Analysis page.
